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Abstract Cytogenetic studies of acute monoblastic leukemia cases presenting MLL-MLLT10 (alias MLL-
AF10) fusion show a broad heterogeneity of chromosomal breakpoints. We present two new pediatric
cases (French–American–British type M5) with MLL-MLLT10 fusion, which we studied with fluo-
rescence in situ hybridization. In both we detected a paracentric inversion of the 11q region that
translocated onto chromosome 10p12; one case displayed a variant complex pattern. We review the
cytogenetic molecular data concerning the proximal inversion breakpoint of 11q and confirm its
heterogeneity.  2004 Elsevier Inc. All rights reserved.1. Introduction
Chromosome rearrangements involving the mixed lineage
leukemia (MLL) gene at the 11q23 locus occur in ~5–10% of
acute leukemias, mainly of myeloid or poorly differentiated
lymphoid origin, and are associated with poor prognosis
[1–3]. To date, 37 partners of MLL have been identified [4]. In
particular, two genes may be involved in t(10;11): SSH3BP1
(alias ABI-1; also ABI1), which is a human homolog to the
mouse Abl interactor 1 at 10p11.2, and which has been
described in only three cases of pediatric acute monocytic
leukemia [5–7], and MLLT10 (alias AF10) at 10p13, which
is more commonly fused to MLL [8]. The majority of the
other MLL rearrangements result from a reciprocal transloca-
tion, but MLL-MLLT10 fusions require more complex chro-
mosome rearrangements. These various mechanisms have
recently been elucidated by Van Limbergen et al. [3]. All
the 11q23 translocations involving MLL lead to fusion genes
in which the 5′ part belongs to MLL [9]. The expression of
a chimeric product requires the same orientation of the two
fused genes: because the direction of MLL transcription is
centromere to telomere, an inversion has to occur if the
partner gene is oriented in the opposite way [9]. Four recom-
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doi:10.1016/j.cancergencyto.2003.11.012bination patterns have been proposed: types 1 and 2 result
from inversion of 11q13~q14-q23 involving the MLL locus,
followed by translocation with (type 1) or insertion into
(type 2) 10p12; the two other types require the inversion of
MLLT10 gene followed by translocation with (type 3) or
insertion into (type 4) 11q23 [3]. We present two new cases
of pediatric acute monoblastic leukemia with MLL-MLLT10
fusion of type 2 (according to Van Limbergen et al. [3]),
one of them showing involvement of a third chromosome.
We also briefly discuss the variability of the breakpoint on
11q centromeric to MLL gene in this particular mechanism.
2. Case reports
2.1. Patient 1
At 4 months of age, hyperleukocytosis (a white blood
cell [WBC] count of 41 × 109/L) prompted a diagnosis of
acute myeloid leukemia (AML), French–American–British
(FAB) type M5a. Blast immunophenotype was character-
ized by a positivity of HLA-DR, CD45, CD34, CD33,
CD11a, CD11b, CD11c, CD15, CD7, CD19, and CD38.
The child was enrolled in protocol AML-BFM 93 [10] and
achieved clinical remission. At 4 months from diagnosis,
however, leukemia recurred, with the presence of blasts in
cerebrospinal fluid and partial (9%) marrow involvement.
Bone marrow transplantation (BMT) from a partially
matched related donor was performed after conditioning
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cal cytarabine. At 5 months after BMT, a second hematologi-
cal and central nervous system (CNS) relapse occurred;
further remission with full donor chimerism was achieved
following enrollment in IDA FLAG/FLAG protocols [11], as
confirmed by the absence of recipient-derived DNA through
short tandem repeat polymorphism analysis of BM cells.
A second BMT from the same donor was successfully
performed, and at writing the patient was alive and in third
complete remission, 24 months after retransplant.
2.2. Patient 2
When the patient was 8 months old, a diagnosis was made
of AML FAB M5 with CNS and cutaneous involvement.
The patient was enrolled in an ongoing international protocol
for infant leukemia (Interfant 99: dexamethasone, vincris-
tine, daunorubicin, cytarabine, l-asparaginase, methotrex-
ate, cyclophosphamide, and mercaptopurine) and achieved
hematological, liquoral, and cutaneous remission. After 8
months of treatment, hematological and CNS relapse oc-
curred. A second-line chemotherapy course (FLAD: fludar-
abine, cytarabine, and liposomal daunorubicin), delayed dueto interstitial pneumonia, produced a partial response with
persistence of residual blasts in bone marrow, CNS and cutis
(leukemoids). The child underwent allogeneic BMT from
a match-unrelated donor (female) after conditioning with
busulfan–thiotepa–etoposide and intrathecal cytarabine;
however, lymph node relapse occurred 2 months after trans-
plant and the child died shortly after with progressive
disease.
3. Materials and methods
At onset or relapse (or both), chromosome analyses were
performed on unstimulated peripheral blood (PB) and bone
marrow (BM) from both patients, and on lymph node blasts
from patient 2, using a QFQ-banding technique. A minimum
of 20 metaphases were screened. Karyotype designation was
according to International System for Human Cytogenetic
Nomenclature (ISCN 1995) [12]. Fluorescence in situ hybrid-
ization (FISH) analyses were performed according to the
manufacturer’s protocols using whole-chromosome 7, 10,
and 11 painting probes (wcp) (Appligene Oncor-Qbiogene,
Illkirch, France) and using the LSI MLL dual-color probeFig. 1. Ideograms of the 11q arm, with schematic representation of FISH studies in (A) patient 1 and (B) patient 2. Dotted lines show breakpoints; arrowheads
indicate the regions of 11q chromosome inversion.
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gene at 11q23. Human DNA inserts of yeast artificial chro-
mosome (YAC) were amplified using Alu-polymerase chain
reaction as previously described [13]. YAC or bacterial arti-
ficial chromosome (BAC) probes were labeled with nick
translation with biotin-16- or digoxigenin-11-dUTP (Roche,
Mannheim, Germany) and visualized using streptavidin-Cy3
(Amersham Pharmacia Biotech, Buckinghamshire, UK) and
sheep antidigoxigenin-FITC (Roche). The following YAC
or BAC probes were used: RP11-418C1 located telomeric
to MLLT10 and also containing the 5′ part of the gene
cohybridized with RP11-249M6 located centromeric to
MLLT10 and also containing the 3′ part of the gene; RP11-
141J21 cohybridized with RP11-665N17, both located at
11q13.1, centromeric and telomeric to the marker PYGM
(muscle glycogen phosphorylase gene), respectively [9];
YAC 946_f_4 (11q14.1) cohybridized with YAC 932_f_8
(11q21); RP11-103I15 containing the PICALM gene (alias
CALM, CLTH) at 11q14.2 cohybridized with RP11-12D16
located telomeric to PICALM; subtelomeric 10p RP11-145I2cohybridized with subtelomeric 11q RP11-209L12. Images
were captured on a Zeiss Axioplan microscope (Carl Zeiss,
Jena, Germany) equipped with a charge-coupled device
(CCD) camera. Adobe Photoshop software (Adobe Systems,
Seattle, WA) was used to pseudocolor and merge images.
4. Results and discussion
4.1. Patient 1
Cytogenetic analysis performed on BM blasts revealed a
chromosome 10;11 rearrangement. FISH studies are outlined
in Fig. 1A. FISH analyses with wcp 10 and 11 and with 10p
and 11q subtelomeric probes revealed insertion of chromo-
some 11q material into the short arm of chromosome 10.
Hybridization signals for the MLL dual probe were split,
with localization of the 5′ part of MLL on the proximal
region of 11q inserted into 10p, while the 3′ part of MLL
was retained on the derivative chromosome 11. Dual-color
FISH showed that probes for the 3′ (RP11-249M6) and 5′Fig. 2. FISH analyses of the 11q proximal inversion breakpoint in metaphase cells of (A, B) patient 1 and (C, D) patient 2. (A) YACs 946_f_4 at 11q14.1
(green) and 932_f_8 at 11q21 (red) were present on the normal chromosome 11 (arrowhead) and on the der(10) (arrow). (B) RP11-141J21 (red) and
RP11-665N17 (green) at 11q13.1, centromeric and telomeric to the PYGM gene, respectively, both localized on the normal chromosome 11 (arrowhead)
and on the der(11) (arrow). (C) Hybridization signals of YACs 946_f_4 at 11q14.1 (green) and 932_f_8 at 11q21 (red) are localized on the der(7) (arrow) and
the der(10) (arrowhead), respectively. (D) RP11-103I15 (red) containing the PICALM gene at 11q14.2 and RP11-12D16 (green) telomeric to PICALM were
present on the normal chromosome 11 (arrowhead) and on the der(10) (arrow).
Morerio et al. / Cancer Genetics and Cytogenetics 152 (2004) 108–112 111
Table 1
Proximal inversion breakpoints at 11q detected with FISH
Casea Mechanism typeb Probe Breakpoint region Reference
a 1 variant PYGM/3.16 11q10~11q13.1 Patient 3 in Beverloo et al., 1995 [9]
b 1 PYGM/3.16 11q13.1~11q21 Patient 5 in Beverloo et al., 1995 [9]
c 2 variant 946_f_4/932_f_8 11q14.1~11q21 Patient 1 in Van Limbergen et al., 2002 [3]
d 1 RP11-665N17/946_f_4 11q13.1~11q14.1 Patient 1, present study
e 2 variant 946_f_4/RP11-103I15 11q14.1~11q14.2 Patient 2, present study
a Cases correspond to a–e in Fig. 3.
b Classification according to Van Limbergen et al. [3].(RP11-418C1) regions of MLLT10, which normally hybrid-
ize on the short arm of chromosome 10, were located at
either side of the inserted 11q segment. Hybridization signals
for YAC 946_f_4 (11q14.1) and YAC 932_f_8 (11q21) both
localized on the inserted 11q segment (Fig. 2A), whereas
RP11-141J21 and RP11-665N17 (PYGM) signals were re-
tained on the derivative chromosome 11 (Fig. 2B). The
karyotype thus was 46,XY,ins(10;11)(p12;q23q13).
4.2. Patient 2
The karyotype of PB and BM blasts at onset and at re-
lapse was described as 46,XY,t(7;11;10)(q21;q21;p15). At
second relapse after BMT, the karyotype of lymph node
blasts revealed an additional chromosomal anomaly:
46,XY,t(1;4)(p32;q31),t(7;11;10)(q21;q21;p15). FISH anal-
yses summarized in Fig. 1B detail the complex re-
arrangement that occurred. FISH with wcp 7, 10, and 11 and
with subtelomeric probes for 10p-tel (RP11-145I2) and 11q-
tel (RP11-209L12) revealed an insertion of chromosome
11 material into the short arm of chromosome 10 and the
reciprocal translocation between the telomeric portion of
11q and part of chromosome 7 long arm. Hybridization
signals for the MLL dual probe were split: the 5′ part of
MLL was inserted into 10p and the 3′ part of MLL was
translocated onto the derivative chromosome 7; no MLL
signal was observed on the derivative chromosome 11. Dual-
color FISH using probes for the 3′ (RP11-249M6) and 5′
(RP11-418C1) parts of MLLT10 localized both signals on
the short arm of the derivative chromosome 10, split at the
proximal and distal ends of 11q inserted segments, respec-
tively. Hybridization signals for YAC 946_f_4 (11q14.1) and
YAC 932_f_8 (11q21) were localized on derivative chromo-
some 7 and on the distal part of inserted 11q segment,
respectively (Fig. 2C). Cohybridization between PICALM
probes RP11-103I15 and RP11-12D16 showed both signals
retained on the distal part of the 11q inserted segment
(Fig. 2D). After FISH analysis, the revised karyotype was
46,XY,t(7;10;11)(7pter→7q11.2::11q13→11q14.1::11q23→
11qter;10pter→10p12::11q14.2→11q23::10p12→10qter;11
pter→11q13::7q11.2→7qter).The t(10;11)(p12;q23) is associated mainly with acute
monocytic leukemias, frequently with CNS disease and/or
skin involvement [14], as in the two patients described here.
The breakpoint cluster region on 11q23 spans an 8.3-kb
segment of genomic DNA, comprising exons 5–10 of the
MLL gene [8]. The t(10;11) produces a MLL-MLLT10 tran-
script originating from the fusion of the 5′ end of MLL and
the 3′ end of MLLT10: the MLL-AF10 chimeric protein
contains the AF10 leucine-zipper motif [8] required for im-
mortalization of myeloid progenitors in vitro and endowed
with leukemogenic capacity in vivo [15]. Up to now, the
pattern of 10;11 chromosomal rearrangements has been
determined with molecular cytogenetics in 30 cases
[3,16,17]. Our two cases show a type 2 pattern according
to Van Limbergen’s classification: the first case is a more
typical ins(10;11) and the second case involves a third chro-
mosome, requiring at least five breakpoints. A variant com-
plex rearrangement involving more than two chromosomes,
as in our patient 2, had been reported in only five previ-
ous cases [3,16,17]. The mechanism of type 1 and 2 re-
arrangements requires two breaks (at 11q13~q21 and 11q23,
respectively), followed by paracentric inversion of the 11q
segment including the 5′ part of MLL and its insertion or
translocation into 10p12. The proximal breakpoint of the
Fig. 3. Schematic illustration of proximal inversion breakpoints: a and b
correspond, respectively, to patients 3 and 5 reported by Beverloo et al.
[9], c corresponds to patient 1 reported by Van Limbergen et al. [3], d and
e to our patients 1 and 2.
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fied through molecular cytogenetics in only three cases [3,9]
prior to the present two cases (Table 1; Fig. 3). The heteroge-
neity of the proximal breakpoint locations seems to be con-
firmed, because the regions defined do not overlap. To better
define the complex rearrangements occurring between 10p
and 11q, which are often unclear following standard cytoge-
netic analysis alone, the use of FISH techniques is needed.
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